US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Manufacturing, Packaging & Detailing Market Research Reports & Industry Analysis

RSS Feeds

Manufacturing, Packaging & Detailing Industry Research & Market Reports

3  4  5  6    8    10  11  12  
Romania Pharmaceutical Report - Q2, 2014
9/4/2014 | published by: Intellinews
... to RON 3bn (EUR 679.8mn) in Q2/2014, returning to growth after having declined on an annual basis for three consecutive quarters. In volume terms, the market also rose by 3.2% y/y in Q2, recovering from ...  |  read more...
USD 475
Binge Eating Disorder - Pipeline Review, H2 2014
8/25/2014 | published by: Global Markets Direct
... information on the therapeutic development for Binge Eating Disorder, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest ...  |  read more...
USD 2,000
CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - Australia
9/1/2014 | published by: GlobalData
... information on and analysis of the healthcare, regulatory and reimbursement landscape in Australia. It identifies the key trends in the country‚Äôs healthcare market and provides insights into its demographic, regulatory, and reimbursement landscape and healthcare ...  |  read more...
USD 1,995
Brazil Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... aresignificant revenue-generating opportunities for drugmakers, medical device companies and healthcareservice providers. However, multinationals will continue to face increasing government intervention anddomestic competition. Headline Expenditure Projections Pharmaceuticals: BRL57.0bn (USD26.4bn) in 2013 to BRL62.0bn (USD26.6bn) in 2014; ...  |  read more...
USD 1,295
Canada Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... regulatory authority also encourages pharmaceutical companies to invest in research anddevelopment. However, cost containment policies in the public healthcare sector will continue to putpressure on Canada's medicine prices. Headline Expenditure Projections Pharmaceuticals: CAD25.6bn (USD24.9bn) in ...  |  read more...
USD 1,295
Bahrain Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... to only moderategrowth in the short term. Longer term, the country's ageing population, increasing chronic diseases burdenand robust economic growth will drive medicine demand; however, further medicine price cuts, lower-thanexpectedoil prices in coming years and ...  |  read more...
USD 1,295
Anti-Counterfeiting Packaging Market by Technology (Authentication & Anti-Tempering, and Track & Trace), by Application (Food & Beverage, Pharmaceuticals, and Others) - Global Trends & Forecast to 2019
8/12/2014 | published by: MarketsandMarkets
... is projected to record a CAGR of 14.1% from 2014 to 2019. The estimation is a result of new products & technologies launches in the industry, with increase in application of anti-counterfeit in different economies. ...  |  read more...
USD 4,650
Best Practices - 2014 Life Science Manufacturing and Supply Chain IT Benchmark Guide
8/12/2014 | published by: IDC
... projected to experience strengthening growth going forward. Eric Newmark, program director at IDC Health Insights, commented, "Life science companies are exploring opportunities to further optimize manufacturing and supply chain processes to help solve several industry ...  |  read more...
USD 4,500
Belgium Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... per capita spending onpharmaceuticals is relatively high, it is subjected to continual downward pressure from Eastern Europe andAsia, which translates into growth opportunities for generic drugs. However, prescribers' brand loyalty,pay-to-delay deals, the near-universal unpopularity of ...  |  read more...
USD 1,295
Kenya Pharmaceuticals and Healthcare Report - Q4 2014
8/20/2014 | published by: Business Monitor International
... healthcare spending between2013 and 2018. However, we note that there are downside risks to our forecast, including governmentinefficiencies and the out-of-pocket characteristics of the market, which will act as challenges forcompanies looking for a rapid ...  |  read more...
USD 1,295
Thailand Pharmaceuticals and Healthcare Report - Q4 2014
8/20/2014 | published by: Business Monitor International
... with access tohealthcare. However cost containment policies and delays in patent approvals limit the attractiveness of thecountry to multinational pharmaceutical firms. Headline Expenditure Projections Pharmaceuticals: THB142.5bn (USD4.64bn) in 2013 to THB146.5bn (USD4.5bn) in 2014; +2.8% ...  |  read more...
USD 1,295
Germany Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... putting furtherpressure on drugmakers looking to benefit from marketing their products in other European markets. Despite this situation, Germany will remain an attractive market to drugmakers. The long-term and clearnature of the price measures implemented ...  |  read more...
USD 1,295
Australia Pharmaceuticals and Healthcare Report - Q4 2014
8/20/2014 | published by: Business Monitor International
... price disclosure (SPD) cycle inAustralia. As a result, the prices of the affected drugs will be lowered by 20% on average, from those inApril 2014. The Australian government continues to push price controls on pharmaceuticals. ...  |  read more...
USD 1,295
Latvia Pharmaceuticals and Healthcare Report - Q4 2014
8/20/2014 | published by: Business Monitor International
... strong although thecountry will continue to present a modest opportunity to larger multinational companies on account of itsrelatively small market size. Meanwhile, tensions between Ukraine and Russia may provide challenges forlocal manufacturers looking towards exports ...  |  read more...
USD 1,295
Hungary Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... risk team also sees potential headwindsto spending growth, namely Hungary's excessive government deficits. Under Deficit Procedure rules,Hungary will be forced to trim back its fiscal spending, with negative implications for healthcare. Pricingpressures and slow uptake ...  |  read more...
USD 1,295
Jordan Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... stillprevalent in the market, although steps are being taken to combat this, such as the Jordan Food and DrugAdministration (JFDA)'s recent conference. Although we forecast growth for both the pharmaceutical andhealthcare sectors, our outlook is ...  |  read more...
USD 1,295
Romania Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... in theconsumer outlook and the country's macroeconomic prospects, in line with the views of our Country Riskteam. Provided unemployment continues to pare down and economic growth continues, the pharmaceuticalmarket will continue on its current growth ...  |  read more...
USD 1,295
Cote d'Ivoire Pharmaceuticals and Healthcare Report - Q4 2014
9/10/2014 | published by: Business Monitor International
... lack of policy enforcement and approvalsexpediency and a generally weak business setting. The healthcare market remains underdeveloped, whilethe burden of communicable diseases is considerable. Nevertheless, we have a more positive outlook foreconomic and pharmaceutical growth ...  |  read more...
USD 1,295
Outsourcing in Drug Discovery: The Contract Research Organization (CRO) Market, 6th Edition
4/30/2014 | published by: Kalorama Information
... in depth look into the trends that have shaped the drug discovery outsourcing market today, and details the current and future global market. As part of its coverage, the report provides markets and forecasts for ...  |  read more...
USD 3,995
Pain Medication OTC Manufacturing in Australia - Industry Market Research Report
6/19/2014 | published by: IBISWorld
... opioid analgesics dispensed via prescription are not included in the industry. This report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year ...  |  read more...
USD 965
Generic and Innovative Drugs Market in Ukraine 2014. - Development Forecasts for 2014-2019.
8/1/2014 | published by: PMR
... Which are the most influential manufacturers of generic and innovative drugs for the Ukrainian market? What reimbursement policies will most likely influence this market in the near future? Which data exclusivity rules apply to the ...  |  read more...
USD 1,330
Pharmaceutical Product Manufacturing in Australia - Industry Market Research Report
7/30/2014 | published by: IBISWorld
... blood serums and biotech products. Industry products are distributed directly by the manufacturer or via wholesalers to hospitals and community pharmacies. This report covers the scope, size, disposition and growth of the industry including the ...  |  read more...
USD 965
Generic and Innovative Drugs Market in Russia 2014.- Development Forecasts for 2014-2019.
8/1/2014 | published by: PMR
... expanding selection of generics and innovative treatments available in Russia? Which company manufactures the largest quantity of generic drugs and innovative treatments for this market? How is pricing determined in this market and how does ...  |  read more...
USD 1,330
Water for Pharmaceuticals
7/31/2014 | published by: Global Water Intelligence (Media Analytics)
... industry is turning to drastic business models to maximise their revenues. Water is a core business for the pharmaceutical industry, and these developments will ultimately have a knock-on effect on the water for pharmaceuticals market. ...  |  read more...
USD 2,185
Biological Products Manufacturers: State Industry Market Evaluator
6/30/2014 | published by: BizMiner
... volume, average firm, site and small business sales, sales per employee, market volume by employment class, employment by employment class and more. Additional statistics include failure rates (firms, establishments, small business, startups). startup activity rates ...  |  read more...
USD 699
3  4  5  6    8    10  11  12